Skip to content
Lower risk Drug recall · FDA · Published June 10, 2022

Akorn Calcipotriene Topical Solution Recall: Defective Delivery System

Akorn recalls 0.005% Calcipotriene Topical Solution (Scalp Solution) due to potential delivery system defect preventing proper dispensing. Rx only, 60mL bottles manufactured by HI-TECH.

🇺🇸 FDA recall #D-1170-2022DrugAkorn ›
Take action

Contact the company

Recalling firmAkorn, Inc.1925 W Field Ct Ste 300 · Lake Forest, IL 60045-4862
✎ GovInfoNow plain-language explainer

Akorn is recalling 0.005% Calcipotriene Topical Solution (Scalp Solution) because the delivery system might not work properly. This could mean the medication doesn't dispense as intended, which is important for people using it under a doctor's supervision. Read more at govinfonow.com/recall/34628-akorn-calcipotriene-topical-solution-recall-defective-delivery-system.

Source Summary by GovInfoNow · govinfonow.com/recall/34628-akorn-calcipotriene-topical-solution-recall-defective-delivery-system · Updated August 18, 2026 · FDA enforcement record: FDA #D-1170-2022

Cite this page

“Akorn Calcipotriene Topical Solution Recall: Defective Delivery System.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/34628-akorn-calcipotriene-topical-solution-recall-defective-delivery-system. Based on FDA recall #D-1170-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1170-2022%22&limit=1).

The FDA announced on June 10, 2022, that Akorn, Inc. is recalling Calcipotriene Topical Solution due to a defective delivery system that may prevent dispensing. The recall affects 2,736 bottles distributed nationwide.

How to tell if you have it

  • Brand: Akorn
  • Product: Calcipotriene Topical Solution, 0.005% (Scalp Solution), Rx only, 60 mL (2 fl. oz.) bottle
  • Manufacturer: HI-TECH PHARMACAL CO., INC.
  • NDC: 50383-732-02
  • Lot #: 378440
  • Expiration Date: 07/31/2023

The hazard

The product has a potential defect that could prevent it from dispensing as intended, according to the FDA.

Context

GovInfoNow's records show Akorn, Inc. has had 64 other recalls on record since August 5, 2014. Other recent recalls of similar products include Rifampin Capsules 300mg (April 26, 2023), Atropine Sulfate Ophthalmic Solution 1% (January 30, 2023), and Levofloxacin Ophthalmic Solution 0.5% (October 13, 2022).

How to tell if you have this one

Check for the 60 mL (2 fl. oz.) bottle labeled 'Calcipotriene Topical Solution, 0.005% (Scalp Solution), Rx only'. The product was manufactured by HI-TECH PHARMACAL CO., INC. in Amityville, N.Y. with NDC 50383-732-02 and lot number 378440.

  • Brand
    Akorn
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the product label matches the description: 60 mL (2 fl. oz.) bottle, 'Calcipotriene Topical Solution, 0.005% (Scalp Solution), Rx only'.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the U.S.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 16 months after the firm started it.

1. Firm started the recall: Jun 10, 202212. FDA classified it Class II: Jun 29, 202223. Published in FDA’s Enforcement Report: Jul 6, 202234. FDA terminated the recall: Sep 28, 2023420222023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1170-2022 (June 10, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1170-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA